IT201600117326A1 - Linee cellulari stabili per la produzione retrovirale. - Google Patents
Linee cellulari stabili per la produzione retrovirale.Info
- Publication number
- IT201600117326A1 IT201600117326A1 IT102016000117326A IT201600117326A IT201600117326A1 IT 201600117326 A1 IT201600117326 A1 IT 201600117326A1 IT 102016000117326 A IT102016000117326 A IT 102016000117326A IT 201600117326 A IT201600117326 A IT 201600117326A IT 201600117326 A1 IT201600117326 A1 IT 201600117326A1
- Authority
- IT
- Italy
- Prior art keywords
- cell lines
- stable cell
- retroviral production
- retroviral
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
- C12N7/025—Packaging cell lines, e.g. transcomplementing cell lines, for production of virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/045—Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/867—Retroviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/867—Retroviral vectors
- C12N15/8673—Special methods for packaging systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
- C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
- C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/40—Vector systems having a special element relevant for transcription being an insulator
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Seal Device For Vehicle (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1520761.6A GB201520761D0 (en) | 2015-11-24 | 2015-11-24 | Stable cell lines for retroviral production |
GBGB1609303.1A GB201609303D0 (en) | 2016-05-26 | 2016-05-26 | Stable cell lines for retroviral production |
Publications (1)
Publication Number | Publication Date |
---|---|
IT201600117326A1 true IT201600117326A1 (it) | 2018-05-21 |
Family
ID=57354376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102016000117326A IT201600117326A1 (it) | 2015-11-24 | 2016-11-21 | Linee cellulari stabili per la produzione retrovirale. |
Country Status (17)
Country | Link |
---|---|
US (3) | US20170145388A1 (it) |
EP (2) | EP3489353B8 (it) |
JP (1) | JP7098521B2 (it) |
KR (1) | KR102091957B1 (it) |
CN (1) | CN108291208A (it) |
AU (1) | AU2016360763B2 (it) |
BR (1) | BR112018010635A2 (it) |
CA (1) | CA3006288A1 (it) |
DE (1) | DE102016122316A1 (it) |
ES (2) | ES2939617T3 (it) |
FR (1) | FR3044016A1 (it) |
GB (1) | GB2544892B (it) |
IL (2) | IL259254A (it) |
IT (1) | IT201600117326A1 (it) |
RU (1) | RU2752498C2 (it) |
SA (1) | SA518391623B1 (it) |
WO (1) | WO2017089308A1 (it) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7816612B2 (en) * | 2005-12-21 | 2010-10-19 | Ishida Co., Ltd. | Rotary measuring device |
RU2749717C2 (ru) | 2015-11-24 | 2021-06-16 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Способ временной трансфекции для продуцирования ретровируса |
GB201706121D0 (en) * | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Stable cell lines for retroviral production |
GB201715052D0 (en) | 2017-09-19 | 2017-11-01 | Oxford Genetics Ltd | Vectors |
EP3696272A1 (en) | 2017-12-22 | 2020-08-19 | Oxford BioMedica (UK) Limited | Retroviral vector |
JP2022551219A (ja) * | 2019-08-23 | 2022-12-08 | ロンザ ウォーカーズヴィル,インコーポレーテッド | レンチウイルスベクターの製造方法および構築物 |
EP4077642A1 (en) * | 2019-12-18 | 2022-10-26 | Lonza Walkersville, Inc. | Methods and constructs for transient production of lentiviral vector |
GB202004371D0 (en) | 2020-03-26 | 2020-05-13 | Glaxosmithkline Ip Dev Ltd | CAR constructs |
GB202005096D0 (en) | 2020-04-07 | 2020-05-20 | Glaxosmithkline | Modified vectors for production of retrovirus |
CN113528515B (zh) * | 2020-04-22 | 2023-05-05 | 中国科学院分子植物科学卓越创新中心 | 基于CRISPR-Cas13a干预阻断病毒逆转录转座的技术 |
CA3183599A1 (en) * | 2020-05-15 | 2021-11-18 | Ivexsol, Inc. | Compositions and methods for producing stable viral vector producer cells for cell and gene therapy |
CN112430582B (zh) * | 2020-12-04 | 2022-05-03 | 北京艺妙神州医药科技有限公司 | 一种慢病毒稳定包装细胞系及其制备方法 |
AR125136A1 (es) | 2021-03-19 | 2023-06-14 | Glaxosmithkline Ip Dev Ltd | Receptores de antígenos quiméricos dirigidos a claudina-3 y métodos para tratar el cáncer |
US20240200100A1 (en) * | 2021-04-20 | 2024-06-20 | The Regents Of The University Of California | Packaging cells with targeted gene knockouts that improve retroviral vector titers |
WO2024149284A1 (en) * | 2023-01-10 | 2024-07-18 | Nanjing Legend Biotech Co., Ltd. | Regulatory sequences and uses thereof |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
WO1995003400A1 (en) * | 1993-07-23 | 1995-02-02 | Johns Hopkins University School Of Medicine | Recombinationally targeted cloning in yeast artificial chromosomes |
SI0835137T1 (sl) * | 1995-06-27 | 2006-04-30 | Bavarian Nordic As | Inkapsulirane celice, ki proizvajajo virusne delce |
FR2751223B1 (fr) * | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
US6677155B1 (en) * | 1999-04-22 | 2004-01-13 | The General Hospital Corporation | Triple hybrid amplicon vector systems to generate retroviral packaging lines |
EP1179083A4 (en) * | 1999-04-22 | 2003-04-23 | Gen Hospital Corp | VECTOR SYSTEM OF TRIPLIC HYBRID AMPLICONS FOR THE GENERATION OF PACKAGING LINES |
AU4559800A (en) * | 1999-04-29 | 2000-11-17 | Aarhus Universitet | Expression of heterologous genes from an ires translational cassette in retroviral vectors |
US20060057553A1 (en) * | 2000-05-30 | 2006-03-16 | Estuardo Aguilar-Cordova | Chimeric viral vectors for gene therapy |
US6689601B2 (en) | 2000-09-01 | 2004-02-10 | E. I. Du Pont De Nemours And Company | High growth methanotropic bacterial strain |
US6586251B2 (en) * | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
DE10111433A1 (de) * | 2001-03-09 | 2002-09-19 | Bundesrepublik Deutschland Let | Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen |
EP1390384A4 (en) | 2001-05-30 | 2005-08-17 | Chromos Molecular Systems Inc | PLATFORMS ON CHROMOSOME BASIS |
US6835568B2 (en) * | 2001-10-30 | 2004-12-28 | Virxsys Corporation | Regulated nucleic acid expression system |
DK2348119T3 (en) * | 2002-02-01 | 2017-08-21 | Oxford Biomedica (Uk) Ltd | Polycistronic lentiviral vector |
CA2501168A1 (en) * | 2002-11-25 | 2004-06-10 | Bavarian Nordic A/S | Recombinant poxvirus comprising at least two cowpox ati promoters |
JP5690038B2 (ja) * | 2004-04-28 | 2015-03-25 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 多価ウイルスベクターおよびその作製のためのシステム |
EP1652932A1 (en) * | 2004-11-02 | 2006-05-03 | GBF Gesellschaft für Biotechnologische Forschung mbH | Method for the generation of virus producing cell lines and cell lines |
EP1829963A4 (en) * | 2004-11-24 | 2009-01-28 | Anaeropharma Science Inc | NEW SHUTTLE VECTOR |
GB0702695D0 (en) * | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Production of vectors |
EP2193879B1 (de) | 2008-12-05 | 2012-08-01 | Mikron Agie Charmilles AG | Werkzeugreinigung |
JPWO2010131747A1 (ja) * | 2009-05-15 | 2012-11-08 | 国立大学法人 東京大学 | ウイルス産生細胞 |
US9441245B2 (en) * | 2010-09-02 | 2016-09-13 | Molmed S.P.A. | Stable production of lentiviral vectors |
US9273324B2 (en) * | 2010-12-05 | 2016-03-01 | Andrew S. Belmont | Recombinant gene expression |
WO2012170431A2 (en) * | 2011-06-06 | 2012-12-13 | Bluebird Bio, Inc. | Improved geneswitch systems |
FR2979919B1 (fr) * | 2011-09-12 | 2015-12-11 | Centre Nat Rech Scient | Genomes lentiviraux chimeriques non-integratifs comme vaccins innovants contre vih-1 |
GB201202516D0 (en) * | 2012-02-13 | 2012-03-28 | Ucl Business Plc | Materials and methods relating to packaging cell lines |
JP2015529466A (ja) * | 2012-09-14 | 2015-10-08 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター |
CN104884627A (zh) * | 2012-10-25 | 2015-09-02 | 托卡根公司 | 具有小型启动子盒的逆转录病毒载体 |
EP3039129B1 (en) * | 2013-08-30 | 2018-06-27 | Amgen Inc. | High titer recombinant aav vector production in adherent and suspension cells |
GB2538321A (en) * | 2015-05-15 | 2016-11-16 | Glaxosmithkline Ip Dev Ltd | Artificial chromosome for retroviral production |
GB2538324A (en) * | 2015-05-15 | 2016-11-16 | Glaxosmithkline Ip Dev Ltd | Packaging cell line for retroviral production |
EP3139086B1 (en) * | 2015-09-01 | 2018-05-23 | Philips Lighting Holding B.V. | Lighting device with a wireless communication antenna |
RU2749717C2 (ru) * | 2015-11-24 | 2021-06-16 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Способ временной трансфекции для продуцирования ретровируса |
-
2016
- 2016-11-21 RU RU2018122636A patent/RU2752498C2/ru active
- 2016-11-21 FR FR1661255A patent/FR3044016A1/fr active Pending
- 2016-11-21 KR KR1020187014237A patent/KR102091957B1/ko active IP Right Grant
- 2016-11-21 IT IT102016000117326A patent/IT201600117326A1/it unknown
- 2016-11-21 AU AU2016360763A patent/AU2016360763B2/en active Active
- 2016-11-21 EP EP19151187.2A patent/EP3489353B8/en active Active
- 2016-11-21 EP EP16798512.6A patent/EP3380604B1/en active Active
- 2016-11-21 CN CN201680068650.7A patent/CN108291208A/zh active Pending
- 2016-11-21 US US15/356,830 patent/US20170145388A1/en not_active Abandoned
- 2016-11-21 JP JP2018526799A patent/JP7098521B2/ja active Active
- 2016-11-21 CA CA3006288A patent/CA3006288A1/en active Pending
- 2016-11-21 ES ES16798512T patent/ES2939617T3/es active Active
- 2016-11-21 WO PCT/EP2016/078336 patent/WO2017089308A1/en active Application Filing
- 2016-11-21 ES ES19151187T patent/ES2959326T3/es active Active
- 2016-11-21 DE DE102016122316.6A patent/DE102016122316A1/de not_active Withdrawn
- 2016-11-21 BR BR112018010635A patent/BR112018010635A2/pt active Search and Examination
- 2016-11-21 GB GB1619643.8A patent/GB2544892B/en active Active
-
2018
- 2018-05-09 IL IL259254A patent/IL259254A/en unknown
- 2018-05-20 SA SA518391623A patent/SA518391623B1/ar unknown
- 2018-07-13 US US16/034,517 patent/US20180320147A1/en not_active Abandoned
-
2019
- 2019-12-18 US US16/718,791 patent/US20200123505A1/en not_active Abandoned
-
2021
- 2021-04-23 IL IL282603A patent/IL282603B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3489353C0 (en) | 2023-07-26 |
EP3380604B1 (en) | 2022-12-28 |
IL282603A (en) | 2021-06-30 |
CA3006288A1 (en) | 2017-06-01 |
IL259254A (en) | 2018-07-31 |
WO2017089308A1 (en) | 2017-06-01 |
SA518391623B1 (ar) | 2022-10-30 |
RU2018122636A3 (it) | 2020-04-02 |
RU2752498C2 (ru) | 2021-07-28 |
DE102016122316A1 (de) | 2017-05-24 |
JP7098521B2 (ja) | 2022-07-11 |
KR102091957B1 (ko) | 2020-03-20 |
EP3489353B1 (en) | 2023-07-26 |
GB2544892B (en) | 2017-11-15 |
ES2959326T3 (es) | 2024-02-23 |
FR3044016A1 (fr) | 2017-05-26 |
RU2018122636A (ru) | 2019-12-25 |
GB201619643D0 (en) | 2017-01-04 |
KR20180079351A (ko) | 2018-07-10 |
US20170145388A1 (en) | 2017-05-25 |
EP3489353A1 (en) | 2019-05-29 |
AU2016360763A1 (en) | 2018-05-31 |
CN108291208A (zh) | 2018-07-17 |
US20200123505A1 (en) | 2020-04-23 |
EP3380604A1 (en) | 2018-10-03 |
AU2016360763B2 (en) | 2020-11-05 |
EP3489353B8 (en) | 2023-08-30 |
US20180320147A1 (en) | 2018-11-08 |
JP2018534937A (ja) | 2018-11-29 |
BR112018010635A2 (pt) | 2018-11-27 |
ES2939617T3 (es) | 2023-04-25 |
IL282603B (en) | 2022-05-01 |
GB2544892A (en) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT201600117326A1 (it) | Linee cellulari stabili per la produzione retrovirale. | |
DK3377082T3 (da) | Sammensætninger, der omfatter bakteriestammer | |
DK3303568T3 (da) | Celle | |
DK3122876T3 (da) | Ændret værtscellebane for forbedret ethanolproduktion | |
DK3253762T3 (da) | 9h-pyrrolo-dipyridinderivater. | |
CL2020000951A1 (es) | Célula. | |
IT201600117287A1 (it) | Metodo di trasfezione transiente per produzione retrovirale. | |
DK3254325T3 (da) | Elektrolytdannelsesfremgangsmåde | |
DK3254326T3 (da) | Elektrolytdannelsesfremgangsmåde | |
DK3253906T3 (da) | Elektrolyt til elektroplettering | |
DK3356575T3 (da) | Højtryks- eller differenstrykelektrolysecelle | |
FR3023067B1 (fr) | Cellules tandem multifils | |
ITUB20153968A1 (it) | Elettrocatalizzatori su matrici carbonitruriche | |
ES1150114Y (es) | Abarcón. | |
ITUB20152270A1 (it) | Macchina lava-asciuga pavimenti. | |
DK3250774T3 (da) | Port, især hurtigt løbende port | |
DK3291690T3 (da) | Fodersammensætning | |
GB201508435D0 (en) | Packaging cell line for retroviral production | |
DK3766582T3 (da) | Cellekultur | |
FR3041819B1 (fr) | Bloc de reacteur electrochimique | |
DK3265233T3 (da) | Vertikal-valsemølle | |
DK3206821T3 (da) | Hulfrembringelsessystem | |
GB201520761D0 (en) | Stable cell lines for retroviral production | |
GB201609303D0 (en) | Stable cell lines for retroviral production | |
CL2016000847S1 (es) | Inversor |